$1–$10 Watch: 10 Stocks That Could Explode — July 13, 2026

Introduction Investing in low-priced stocks can be a double-edged sword, offering potential high returns alongside significant risks. This analysis highlights ten stocks priced between $1 and $10 that may present explosive growth opportunities in the near term.

1. SNDL - Sundial Growers Inc. - **Current Price**: $2.30 - **Sector**: Cannabis - **Volume Profile**: Increasing volume indicates accumulation as retail investors show renewed interest. - **Short Interest**: 20% of float. Potential for a short squeeze. - **Catalyst**: Upcoming legislative changes could expand cannabis markets in the U.S. - **Technical Setup**: Bouncing off support at $2.00, showing bullish momentum. - **Risk Factors**: Regulatory changes can adversely impact operations. - **Bull Case Price Target**: $4.00 within 60 days. - **Risk Rating**: 🔴 Very High

2. CLOV - Clover Health Investments Corp. - **Current Price**: $3.10 - **Sector**: Healthcare - **Volume Profile**: Steady accumulation with spikes during earnings announcements. - **Short Interest**: 15% of float indicates potential for short covering. - **Catalyst**: Earnings report expected to beat estimates, showcasing improved member growth. - **Technical Setup**: Recently broke above a descending trendline. - **Risk Factors**: Competition from larger insurers could limit growth potential. - **Bull Case Price Target**: $5.00 within 30 days. - **Risk Rating**: 🔴 Very High

3. MVIS - MicroVision, Inc. - **Current Price**: $4.80 - **Sector**: Technology - **Volume Profile**: Volume has surged as partnerships with automotive companies become public. - **Short Interest**: 25% of float suggests significant short interest. - **Catalyst**: New product launches and partnership announcements could spark interest. - **Technical Setup**: Consolidating near support at $4.50, poised for a breakout. - **Risk Factors**: Product development delays could hinder momentum. - **Bull Case Price Target**: $7.00 within 60 days. - **Risk Rating**: 🔴 Very High

4. ZOM - Zomedica Corp. - **Current Price**: $1.90 - **Sector**: Veterinary Health - **Volume Profile**: Increasing interest as new products gain traction in the market. - **Short Interest**: 18% of float indicates potential for short covering. - **Catalyst**: FDA approval for new diagnostic tools is expected within the quarter. - **Technical Setup**: Recently bounced off a support level at $1.50. - **Risk Factors**: Regulatory setbacks can delay product launches. - **Bull Case Price Target**: $3.50 within 90 days. - **Risk Rating**: 🔴 Very High

5. NAKD - Naked Brand Group Limited - **Current Price**: $2.50 - **Sector**: Consumer Goods - **Volume Profile**: Significant accumulation noted after the company pivoted to e-commerce. - **Short Interest**: 30% of float; high potential for a short squeeze. - **Catalyst**: New marketing campaigns and product launches expected to boost sales. - **Technical Setup**: Trading above a critical $2.10 support level. - **Risk Factors**: Market volatility and consumer preference shifts could impact performance. - **Bull Case Price Target**: $4.00 within 60 days. - **Risk Rating**: 🔴 Very High

6. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.75 - **Sector**: Retail - **Volume Profile**: Volume trends upward as interest in the company's health products increases. - **Short Interest**: 12% of float. - **Catalyst**: New product line launch aimed at health-conscious consumers. - **Technical Setup**: Recently bounced off support at $0.60. - **Risk Factors**: Market size limitations could restrict growth. - **Bull Case Price Target**: $1.50 within 90 days. - **Risk Rating**: 🟡 High

7. AITX - Artificial Intelligence Technology Solutions, Inc. - **Current Price**: $0.90 - **Sector**: Technology - **Volume Profile**: Increased buying activity as AI solutions gain popularity across industries. - **Short Interest**: 15% of float indicates potential for covering. - **Catalyst**: New contracts with security firms for AI technology. - **Technical Setup**: Testing resistance at the $1.00 mark. - **Risk Factors**: Competitive market could limit growth. - **Bull Case Price Target**: $1.50 within 60 days. - **Risk Rating**: 🟡 High

8. GME - GameStop Corp. - **Current Price**: $5.20 - **Sector**: Retail - **Volume Profile**: Volume spikes during earnings season and social media buzz periods. - **Short Interest**: 18% of float, signaling potential for a squeeze. - **Catalyst**: Continued transformation into an e-commerce platform could drive growth. - **Technical Setup**: Currently consolidating around $5.00. - **Risk Factors**: Market sentiment can shift quickly, impacting stock price. - **Bull Case Price Target**: $8.00 within 90 days. - **Risk Rating**: 🔴 Very High

9. BNGO - Bionano Genomics, Inc. - **Current Price**: $4.10 - **Sector**: Biotechnology - **Volume Profile**: Strong accumulation as genomic testing becomes more mainstream. - **Short Interest**: 22% of float. - **Catalyst**: New partnerships for genomic research expected to be announced. - **Technical Setup**: Approaching breakout from a consolidation pattern. - **Risk Factors**: Regulatory issues could slow down growth. - **Bull Case Price Target**: $6.00 within 90 days. - **Risk Rating**: 🔴 Very High

10. TTOO - T2 Biosystems, Inc. - **Current Price**: $1.30 - **Sector**: Healthcare - **Volume Profile**: Increased volume as partnerships in the diagnostic space grow. - **Short Interest**: 14% of float. - **Catalyst**: Potential FDA approval for rapid diagnostics. - **Technical Setup**: Trading near a critical support level, with bullish divergence observed. - **Risk Factors**: Clinical trial failures could hurt stock performance. - **Bull Case Price Target**: $2.50 within 90 days. - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-float, low-price stocks often exhibit higher volatility, which can magnify both gains and losses. The small market capitalization allows for significant price swings on relatively low volumes, providing opportunities for traders willing to take on additional risk. Additionally, these stocks can attract attention from retail investors, especially on social media platforms, further increasing volatility.

How to Trade Them Safely Investors should use position sizing strategies to manage risk effectively, ideally investing only a small portion of their capital in high-risk stocks. Limit orders can help avoid slippage in volatile markets, and timing around catalysts—such as earnings reports or FDA announcements—can maximize potential gains while minimizing exposure to downside risk.

Catalyst Calendar - **CLOV**: Earnings report on July 28, 2026 - **ZOM**: FDA approval decision expected in August 2026 - **SNDL**: Legislative updates expected in late July 2026

Educational content only. Not financial advice. DYOR.